This Article Full Text Full Text (PDF) All Versions of this Article: 54/2/393    most recent HYPERTENSIONAHA.109.133777v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Google Scholar Articles by Bidani, A. K. Articles by Loutzenhiser, R. PubMed PubMed Citation Articles by Bidani, A. K. Articles by Loutzenhiser, R. Related Collections Animal models of human disease Other hypertension Endothelium/vascular type/nitric oxide

(Hypertension. 2009;54:393.)
© 2009 American Heart Association, Inc.

Seventh International Workshop on Structure and Function of the Vascular System

Protective Importance of the Myogenic Response in the Renal Circulation

Anil K. Bidani; Karen A. Griffin; Geoffrey Williamson; Xuemei Wang; Rodger Loutzenhiser

From the Department of Medicine, Loyola University Medical Center and Hines Veterans Affairs Hospital (A.K.B., K.A.G.), Maywood, Ill; Department of Electrical and Computer Engineering, Illinois Institute of Technology (G.W.), Chicago, Ill; and the Smooth Muscle Research Group, University of Calgary (X.W., R.L.), Calgary, Alberta, Canada.

Correspondence to Anil K. Bidani, Loyola University Medical Center, 2160 South First Ave, Maywood, IL 60153. E-mail abidani@lumc.edu

Key Words: autoregulation • hypertension • glomerulosclerosis • nephrosclerosis • tubuloglomerular feedback

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Primary essential hypertension is second only to diabetic nephropathy as a etiology for end-stage renal disease.¹ In addition, coexistent/superimposed hypertension plays a major role in the progression of most forms of chronic kidney disease (CKD), including diabetic nephropathy.^2–5 Nevertheless, the individual risk is very low, with <1% of the hypertensive population developing end-stage renal disease. Such data indicate that there must be mechanisms that normally protect the kidneys from hypertensive injury of a severity sufficient to result in end-stage renal disease. The following Brief Review summarizes the evidence that indicates that the renal autoregulatory response, primarily mediated by the myogenic mechanism, is largely responsible for such protection. Moreover, the differing patterns of renal damage that are observed in clinical and experimental hypertension are best explained when considered in the context of alterations in the renal autoregulatory capacity. Recent data also indicate that hypertensive renal damage correlates most strongly with systolic blood pressure (BP).^6–8 Accordingly, the review further emphasizes the kinetic characteristics of the renal myogenic response to oscillating BP signals that render it particularly capable of providing protection against systolic pressures.

	Patterns of Hypertensive Renal Damage

 
Most individuals with primary hypertension develop the modest vascular pathology of benign nephrosclerosis.⁵ The glomeruli are largely spared, and, therefore, proteinuria is not a prominent feature. Because it progresses fairly slowly with limited ischemic nephron loss, renal function is not seriously compromised, except in some genetically susceptible individuals or groups, such as blacks, in whom a more accelerated course may be seen.^2–5 Thus, the slope of the relationship between . . . [Full Text of this Article]

This article has been cited by other articles:

				H. A. Struijker-Boudier, J. Blacher, B. I. Levy, and M. E. Safar Introduction to the Seventh International Workshop on Structure and Function of the Vascular System Hypertension, August 1, 2009; 54(2): 373 - 374. [Full Text] [PDF]